CVR 29316082Private limited company (ApS)Engroshandel med medicinalvarer og sygeplejeartikler (464610)HinnerupFounded 27 Jan 2006
Gross profit
-5.1K
DKK, annual report 2025
-30.3K on 2024
Result
-6.1K
DKK, annual report 2025
Equity
10.6K
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Rinascibella Group ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexMAKKY HOLDING ApSCVR 29315914, 100% of capital and votes, since 27 Jan 2006
Mehrdad Makkysince 27 Jan 2006
Equity of 10.6K DKK was below half the share capital of 125K DKK at 31 Dec 2025. Under the Companies Act (selskabsloven § 119) management must then account for the company's finances at a general meeting. Dandex estimate, computed 26 Oct 2026.
CVR 29315914100% of capital and votessince 27 Jan 2006
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Holds 100% of capital and votes in MAKKY HOLDING ApS, since 27 Jan 2006
Holding company
CVR 29315914Private limited company (ApS)
Holds 100% of capital and votes in Rinascibella Group ApS, since 27 Jan 2006
This company
Rinascibella Group ApS
CVR 29316082
CVR records founders at incorporation. It does not record whether they are alive or still involved.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 18 | Not reported | Not reported | Not reported | Not reported |
| Gross profit | Not reported | -22 | -3 | 25 | -5 |
| Operating profit | -285 | -22 | -3 | +25 | -5 |
| Result for the year | -292 | -23 | -4 | +24 | -6 |
| Equity | 20 | -3 | -8 | 17 | 11 |
| Total assets | 37 | 26 | 22 | 54 | 40 |
| Employees (average) | Not reported | 0 | 0 | 0 | 0 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | -88.3% | Not reported | Not reported | Not reported | Not reported |
| EBIT margin (overskudsgrad) | -1,594% | Not reported | Not reported | Not reported | Not reported |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -37 | -12note 1 | -13note 1 | -2note 1 | -40note 1 |
| ROIC (afkast af investeret kapital) | -61.8%note 2 | n.m.note 3 | n.m.note 3 | n.m.note 3 | n.m.note 3 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -20 | 9note 1 | 8note 1 | 22note 1 | -15note 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 28 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 26 May 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 27 May 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 30 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 12 Jul 2022
Rinascibella Group ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 10 Jan 2027.
1 registered in CVR.
P-number 1012002293Dyreparken 9, 8382 Hinnerup
